Is this you?
Request access for American Research Corporation with your @bitrialsupport.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall73Recruit58Ops78Sponsor77Ther82
Performance (observed)
Historical trials
337
Completed
190
Terminated/Withdrawn
42
Completion rate
82%
Active now
99
Phase 2
108
Phase 3
164
Realized enrollment
526,747
First study year
1999
Years active
27
Match confidence
high
Enrollment velocity (inf)
19,509
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
722
States
Texas
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Boehringer Ingelheim; SWOG Cancer Research Network; Pfizer; Gilead Sciences; Eli Lilly and Company
CROs
PPD Development, LP
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
unitedstates@bitrialsupport.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall73
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.